Clinical trials
Terminated Carcinoma, Ovarian Epithelial trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
91 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 3 |
| 2002 | 5 |
| 2003 | 3 |
| 2004 | 6 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 9 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 91 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gynecologic Oncology Group | 14 |
| National Cancer Institute (NCI) | 7 |
| Masonic Cancer Center, University of Minnesota | 5 |
| Vanderbilt-Ingram Cancer Center | 5 |
| Amgen | 3 |
| M.D. Anderson Cancer Center | 3 |
| Pfizer | 3 |
| Lyell Immunopharma, Inc. | 2 |
| OHSU Knight Cancer Institute | 2 |
| SWOG Cancer Research Network | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 91 |
| Ovarian Neoplasms | 60 |
| Fallopian Tube Neoplasms | 34 |
| Breast Neoplasms | 18 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Burkitt Lymphoma | 9 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 9 |
| Leukemia, Myeloid, Acute | 9 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 9 |
| Leukemia, Myelomonocytic, Chronic | 9 |
Trials
Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.